See more : Vanta Bioscience Limited (VANTABIO.BO) Income Statement Analysis – Financial Results
Complete financial analysis of BioQuest Corp. (BQST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BioQuest Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- First Choice Bancorp (FCBP) Income Statement Analysis – Financial Results
- Vishay Precision Group, Inc. (VPG) Income Statement Analysis – Financial Results
- Enjoy Technology, Inc. (ENJWQ) Income Statement Analysis – Financial Results
- Uranium Participation Corporation (U.TO) Income Statement Analysis – Financial Results
- Pan African Resources PLC (PAFRF) Income Statement Analysis – Financial Results
BioQuest Corp. (BQST)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.bioquestcorp.com
About BioQuest Corp.
BioQuest Corp. intends to acquire companies in green energy sector in the United States. The company was formerly known as Select-TV Solutions, Inc. and changed its name to BioQuest Corp. in November 2019. BioQuest Corp. was incorporated in 2011 and is based in Newport Beach, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 467.57 | 1.41K | 164.00 | 0.00 | 0.00 | 648.00 | 648.00 | 2.11 |
| Gross Profit | 0.00 | 0.00 | -467.57 | -1.41K | -164.00 | 0.00 | 0.00 | -648.00 | -648.00 | -2.11 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 39.76 | 49.06 | 817.92K | 2.20M | 356.55K | 2.18 | 0.00 | 251.90K | 8.28K | 0.13 |
| Selling & Marketing | 50.00 | 49.01K | 0.00 | 0.00 | 0.00 | 2.17K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 89.76 | 49.06K | 817.92K | 2.20M | 356.55K | 2.18K | 2.18K | 251.90K | 8.28K | 0.13 |
| Other Expenses | 0.00 | 0.00 | 206.70K | 530.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 89.76 | 49.06K | 817.92K | 2.20M | 356.55K | 2.18K | 2.18K | 251.90K | 8.28K | 0.31 |
| Cost & Expenses | 89.76 | 49.06K | 817.92K | 2.20M | 356.55K | 2.18K | 2.18K | 251.90K | 8.28K | 1.81 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 33.57K | 41.60K | 78.62K | 37.64K | 2.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 89.76 | 49.06 | 817.92 | 2.20K | 356.55 | 2.18 | 0.00 | 648.00 | 648.00 | 0.18 |
| EBITDA | -33.57 | -49.06K | -742.40K | -2.29M | -356.55K | -2.18K | -2.18K | -615.54K | -7.63K | -2.25 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -89.76 | -49.06K | -817.92K | -2.20M | -356.55K | -2.18K | -2.18K | -251.90K | -8.28K | -2.42 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -123.24K | -91.60K | -3.10K | -123.41K | -2.48K | 0.00 | 5.00 | -364.28K | 0.00 | 0.00 |
| Income Before Tax | -123.33K | -140.66K | -821.02K | -2.32M | -359.03K | -2.18K | -2.18K | -616.19K | -8.28K | -2.42 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -89.76 | -167.90K | -99.61K | 37.64K | 2.48K | -2.18 | 0.00 | 728.57K | 3.00 | 0.00 |
| Net Income | -123.33 | -140.66K | -721.41K | -2.36M | -361.50K | -2.18K | -2.18K | -616.19K | -8.28K | -2.42 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.01 | -0.07 | -0.29 | -0.09 | -0.02 | -0.02 | -22.77 | 0.00 | -0.12 |
| EPS Diluted | 0.00 | -0.01 | -0.07 | -0.29 | -0.09 | -0.02 | -0.02 | -22.77 | 0.00 | -0.12 |
| Weighted Avg Shares Out | 11.49M | 11.44M | 10.14M | 8.28M | 4.10M | 102.13K | 102.13K | 27.07K | 52.31M | 20.10 |
| Weighted Avg Shares Out (Dil) | 11.49M | 11.44M | 10.14M | 8.28M | 4.10M | 102.13K | 102.13K | 27.07K | 52.31M | 20.10 |
Source: https://incomestatements.info
Category: Stock Reports